These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16114285)

  • 1. [The optimal level of dopaminergic neurotransmission].
    de Haan L
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1721-2. PubMed ID: 16114285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications.
    de Haan L; Lavalaye J; van Bruggen M; van Nimwegen L; Booij J; van Amelsvoort T; Linszen D
    Can J Psychiatry; 2004 May; 49(5):290-6. PubMed ID: 15198464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The dopamin D3 receptor--the gray eminence of pharmacotherapy?].
    Sumegi A; Varga E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):405-11. PubMed ID: 20962360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of schizophrenia and the role of newer antipsychotics.
    Risch SC
    Pharmacotherapy; 1996; 16(1 Pt 2):11-4. PubMed ID: 8778681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia.
    Freedman R
    N Engl J Med; 2003 Oct; 349(18):1738-49. PubMed ID: 14585943
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A; Guillin O
    Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract]   [Full Text] [Related]  

  • 8. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia: an illness of distorted reality.
    Dean B
    Biologist (London); 2000 Sep; 47(4):202-6. PubMed ID: 11153121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT
    Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional role of dopamine D4 receptor in schizophrenia].
    Semba J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):13-20. PubMed ID: 15027326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment.
    Tsai SJ
    Med Hypotheses; 2004; 63(6):1047-50. PubMed ID: 15504573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-based parametric study of frontostriatal abnormalities in schizophrenia patients.
    Tanaka S
    BMC Psychiatry; 2010 Feb; 10():17. PubMed ID: 20187970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychopharmacologic approaches to schizophrenic psychoses].
    Giacardy-Paty M; Soubrouillard C; Blin O
    Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
    Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of D(2) and D(3) receptor activity in vivo: PET scan and prolactin.
    Thomasson-Perret N; Pénélaud PF; Théron D; Gouttefangeas S; Mocaër E
    Therapie; 2008; 63(3):237-42. PubMed ID: 18718212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antipsychotic medications on sleep in schizophrenia.
    Krystal AD; Goforth HW; Roth T
    Int Clin Psychopharmacol; 2008 May; 23(3):150-60. PubMed ID: 18408529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of schizophrenia drugs: a focus on dopaminergic systems.
    Nikam SS; Awasthi AK
    Curr Opin Investig Drugs; 2008 Jan; 9(1):37-46. PubMed ID: 18183530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine and typical antipsychotics.
    Ross DE
    Am J Psychiatry; 2004 Oct; 161(10):1925-6. PubMed ID: 15465996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.